Skip to content

PTHS PTHS Asset turnover

Asset turnover at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
0.6×+0.1×
Scilex Holding Company logo
Scilex Holding CompanySCLX
0.2×-0.4×
Journey Medical Corporation logo
Journey Medical CorporationDERM
0.7×0.0×
Opko Health logo
Opko HealthOPK
0.3×0.0×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
0.5×+0.3×
Theravance Biopharma logo
Theravance BiopharmaTBPH
0.3×+0.1×

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Calculated from PTHS’s reported figures.

Based on trailing twelve months.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's asset turnover?
PTHS (PTHS) reported asset turnover of 0.4× in Q1 2026.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.